251. Discovering the Biological Target of 5-epi-Sinuleptolide Using a Combination of Proteomic Approaches.
- Author
-
Morretta E, Esposito R, Festa C, Riccio R, Casapullo A, and Monti MC
- Subjects
- Actin Cytoskeleton metabolism, Actins metabolism, Animals, Chromatography, Affinity methods, Cytochalasin D pharmacology, Diterpenes isolation & purification, HeLa Cells, Humans, Mass Spectrometry methods, Actin Cytoskeleton drug effects, Anthozoa metabolism, Diterpenes pharmacology, Proteomics methods
- Abstract
Sinuleptolide and its congeners are diterpenes with a norcembranoid skeleton isolated from the soft coral genus Sinularia . These marine metabolites are endowed with relevant biological activities, mainly associated with cancer development. 5- epi -sinuleptolide has been selected as a candidate for target discovery studies through the application of complementary proteomic approaches. Specifically, a combination of conventional chemical proteomics based on affinity chromatography, coupled with high-resolution mass spectrometry and bioinformatics, as well as drug affinity responsive target stability (DARTS), led to a clear identification of actins as main targets for 5- epi -sinuleptolide. Subsequent in-cell assays, performed with cytochalasin D as reference compound, gave information on the ability of 5- epi -sinuleptolide to disrupt the actin cytoskeleton by loss of actin fibers and formation of F-actin amorphous aggregates. These results suggest the potential application of 5- epi -sinuleptolide as a useful tool in the study of the molecular processes impaired in several disorders in which actin is thought to play an essential role., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF